Novartis AG
Angiopoietin-like 4 antibodies and methods of use

Abstract:

The present invention relates to monoclonal antibodies binding to human angiopoietin-like 4 protein (hereinafter, sometimes referred to as "ANGPTL4"), and pharmaceutical compositions and methods of treatment comprising the same.